Sinoway Industrial Co., Ltd.

Entecavir Intermediate Entecavir Intermediate

Entecavir Intermediate
Related Products
  • Mupirocin 12650-69-0

    Details of MupirocinOther Names: mupirocinMF: C26H44O9Place of Origin: Fujian, China (Mainland)Type: Auxiliaries and Other Medicinal Chemicals, Immune Function AgentsGrade Standard: Medicine GradeBran...

  • Atracurium Besylate 64228-81-5

    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton...

  • Ceftiofur Sodium 104010-37-9

    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ...

Basic Information of Entecavir Intermediate

  • CAS No of key intermediates. 1354715-15-3
  • Other Names: CMBC
  • Purity: 97%up
  • Appearance: White or off-white powder
  • Single impurity 0.8%below
  • Total impurity 3%below

Usage of Entecavir Intermediate

  • Entecavir, indications for the product is suitable for active replication of the virus, serum aminotransferase ALT continued to rise or liver histology showed active disease in chronic adult hepatitis B treatment.
  • Nucleosides, when used alone or in combination with other antiretroviral drugs, have been reported to have lactic acidosis and severe fatty hepatomegaly, including deaths.
  • When patients with chronic hepatitis B stop anti-hepatitis B treatment, including entecavir, has been found to have reports of severe acute hepatitis attack. The liver function of patients who discontinue anti-hepatitis B treatment should be closely monitored from clinical and laboratory tests, and should be followed up for at least months. If necessary, resume treatment of hepatitis B virus.

MORE_DETAIL Entecavir Intermediate

Basic Information of Entecavir Intermediate

  • CAS No of key intermediates. 1354715-15-3
  • Other Names: CMBC
  • Purity: 97%up
  • Appearance: White or off-white powder
  • Single impurity 0.8%below
  • Total impurity 3%below

Usage of Entecavir Intermediate

  • Entecavir, indications for the product is suitable for active replication of the virus, serum aminotransferase ALT continued to rise or liver histology showed active disease in chronic adult hepatitis B treatment.
  • Nucleosides, when used alone or in combination with other antiretroviral drugs, have been reported to have lactic acidosis and severe fatty hepatomegaly, including deaths.
  • When patients with chronic hepatitis B stop anti-hepatitis B treatment, including entecavir, has been found to have reports of severe acute hepatitis attack. The liver function of patients who discontinue anti-hepatitis B treatment should be closely monitored from clinical and laboratory tests, and should be followed up for at least months. If necessary, resume treatment of hepatitis B virus.
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//